Scarica l'app Stockscreener
84.64
1.55%
1.2592
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$83.38
Aprire:
$83.16
Volume 24 ore:
2.66M
Relative Volume:
0.61
Capitalizzazione di mercato:
$49.12B
Reddito:
$5.88B
Utile/perdita netta:
$1.34B
Rapporto P/E:
36.03
EPS:
2.3489
Flusso di cassa netto:
$799.60M
1 W Prestazione:
+1.67%
1M Prestazione:
-1.89%
6M Prestazione:
+13.16%
1 anno Prestazione:
+14.56%
Intervallo 1D:
$82.31
$85.12
Intervallo di 1 settimana:
$81.85
$85.12
Portata 52W:
$65.94
$87.89
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Confronta EW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
84.65 | 48.39B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
126.34 | 223.39B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.15 | 136.67B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
350.11 | 135.88B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.32 | 126.37B | 34.76B | 4.79B | 5.21B | 3.7017 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Baird Trims Price Target on Edwards Lifesciences to $87 From $88, Maintains Neutral Rating - marketscreener.com
CMS accepts Edwards request for national TAVR coverage review - MassDevice
Edwards Lifesciences (EW): Analyst Rating Maintained, Price Targ - GuruFocus
BTIG reiterates Buy rating on Edwards Lifesciences stock amid TAVR review - Investing.com
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Global Interventional Cardiology Devices Market is Predicted to Cross ~USD 30 Billion by 2034, Due to the Rising Cardiovascular Disease Burden | DelveInsight - GlobeNewswire Inc.
Edwards Lifesciences Resolves $140 Million Harpoon Medical Case - Bloomberg Law News
Edwards Lifesciences Completes Key Study on SAPIEN XT THV - TipRanks
Squarepoint Ops LLC Acquires 50,924 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
Is There Now An Opportunity In Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Holocene Advisors LP Buys 1,223,460 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
934,449 Shares in Edwards Lifesciences Corporation $EW Bought by Hudson Bay Capital Management LP - MarketBeat
Hudson Bay Capital Management LP Invests $73.08 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Donald Bobo Jr Sells 11,386 Shares - MarketBeat
Elevatus Welath Management Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Bellevue Group AG Sells 82,892 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Banque Transatlantique SA Purchases 24,575 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Insider Sell: Heisz Stone Sells Shares of Edwards Lifesciences C - GuruFocus
VP Bobo Jr Sells 11,386 ($953.7K) Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
Edwards Lifesciences (EW) executive reports stock sales and 7,100-share gift - Stock Titan
Edwards Lifesciences (EW) officer exercises options and sells 1,019 shares - Stock Titan
Edwards Lifesciences (EW) director reports sale of 2,615 shares at $83.41 - Stock Titan
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Shareholder Bobo Donald E Jr Fam Trust Files To Sell 5,900 Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
EW (NYSE: EW) Rule 144 filing details planned sale of 5,900 shares - Stock Titan
Edwards Lifesciences (EW) insider plans Rule 144 sale of 2,615 common shares - Stock Titan
Edwards Lifesciences (NYSE: EW) insider files Form 144 to sell 5,487 shares - Stock Titan
Edwards Lifesciences Reports Strong Earnings and Growth - MSN
Nebula Research & Development LLC Sells 16,819 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Sells 11,340 Shares - MarketBeat
Edwards Lifesciences (EW) executive reports sale of 2,000 shares on Form 4 - Stock Titan
Edwards Lifesciences (NYSE: EW) investor files Rule 144 to sell 2,000 shares - Stock Titan
Edwards Lifesciences Corporation $EW Shares Sold by Glenview Trust co - MarketBeat
Citigroup Adjusts Edwards Lifesciences Price Target to $101 From $96, Maintains Buy Rating - marketscreener.com
State Street Corp Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Insider Sold Shares Worth $2,153,373, According to a Recent SEC Filing - marketscreener.com
Daiwa Securities Group Inc. Acquires 24,475 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Bank of Nova Scotia Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Transcript : Edwards Lifesciences CorporationAnalyst/Investor Day - marketscreener.com
Edwards Lifesciences Corp Officer Sells Shares - TradingView — Track All Markets
VP Bobo Jr Sells 11,340 ($950.6K) Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
Edwards Lifesciences officer exercises 11,340 options and sells shares | EW SEC FilingForm 4 - Stock Titan
Edwards Lifesciences (EW) CEO reports option exercise and stock sales in Form 4 - Stock Titan
VP Bobo Jr Files To Sell 11,340 Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
[144] Edwards Lifesciences Corp SEC Filing - Stock Titan
Edwards Lifesciences (NYSE: EW) Form 144 details 3,863-share planned sale - Stock Titan
Axa S.A. Boosts Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences Corp CFO Sells Shares - TradingView — Track All Markets
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):